BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16199552)

  • 1. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.
    Martin ER; Bronson PG; Li YJ; Wall N; Chung RH; Schmechel DE; Small G; Xu PT; Bartlett J; Schnetz-Boutaud N; Haines JL; Gilbert JR; Pericak-Vance MA
    J Med Genet; 2005 Oct; 42(10):787-92. PubMed ID: 16199552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?
    Bertram L; Mullin K; Parkinson M; Hsiao M; Moscarillo TJ; Wagner SL; Becker KD; Velicelebi G; Blacker D; Tanzi RE
    J Med Genet; 2007 Jan; 44(1):e63. PubMed ID: 17209133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Ronald J; Asahara H; Younkin L; Hella M; Jain S; Gnida E; Younkin S; Fadale D; Ohyagi Y; Singleton A; Scanlin L; de Andrade M; Petersen R; Graff-Radford N; Hutton M; Younkin S
    Hum Mol Genet; 2003 Dec; 12(23):3133-43. PubMed ID: 14559775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
    Miyashita A; Arai H; Asada T; Imagawa M; Matsubara E; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R;
    Hum Mol Genet; 2007 Dec; 16(23):2854-69. PubMed ID: 17761686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.
    Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A
    J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk.
    Gao L; Zhang Y; Deng J; Yu W; Yu Y
    Med Sci Monit; 2016 Jun; 22():1924-35. PubMed ID: 27272392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
    Blomqvist ME; Andreasen N; Bogdanovic N; Blennow K; Brookes AJ; Prince JA
    Neurosci Lett; 2004 Apr; 358(3):220-2. PubMed ID: 15039120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
    Rao S; Ghani M; Guo Z; Deming Y; Wang K; Sims R; Mao C; Yao Y; Cruchaga C; Stephan DA; Rogaeva E
    Neurobiol Aging; 2018 Jun; 66():178.e1-178.e8. PubMed ID: 29395286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
    Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
    Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
    Ertekin-Taner N; Ronald J; Feuk L; Prince J; Tucker M; Younkin L; Hella M; Jain S; Hackett A; Scanlin L; Kelly J; Kihiko-Ehman M; Neltner M; Hersh L; Kindy M; Markesbery W; Hutton M; de Andrade M; Petersen RC; Graff-Radford N; Estus S; Brookes AJ; Younkin SG
    Hum Mol Genet; 2005 Feb; 14(3):447-60. PubMed ID: 15615772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between apolipoprotein E, D10S1225 polymorphisms and late-onset Alzheimer's disease.
    Zhang TS; Wang HQ; Wang WY; He YS; Huang SK
    Chin Med J (Engl); 2006 Feb; 119(4):294-9. PubMed ID: 16537024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
    Martin ER; Lai EH; Gilbert JR; Rogala AR; Afshari AJ; Riley J; Finch KL; Stevens JF; Livak KJ; Slotterbeck BD; Slifer SH; Warren LL; Conneally PM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
    Am J Hum Genet; 2000 Aug; 67(2):383-94. PubMed ID: 10869235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease.
    Liang X; Martin ER; Schnetz-Boutaud N; Bartlett J; Anderson B; Züchner S; Gwirtsman H; Schmechel D; Carney R; Gilbert JR; Pericak-Vance MA; Haines JL
    Hum Mutat; 2007 Nov; 28(11):1065-73. PubMed ID: 17573676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two-stage study.
    Myllykangas L; Wavrant-De Vrièze F; Polvikoski T; Notkola IL; Sulkava R; Niinistö L; Edland SD; Arepalli S; Adighibe O; Compton D; Hardy J; Haltia M; Tienari PJ
    J Neurol Sci; 2005 Sep; 236(1-2):17-24. PubMed ID: 16023140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.